Next Article in Journal
HPLC-DAD-ESI/MS Identification and Quantification of Phenolic Compounds in Ilex paraguariensis Beverages and On-Line Evaluation of Individual Antioxidant Activity
Previous Article in Journal
Effects of Freshwater Clam Extract Supplementation on Time to Exhaustion, Muscle Damage, Pro/Anti-Inflammatory Cytokines, and Liver Injury in Rats after Exhaustive Exercise
Open AccessArticle

Phenylmethimazole Suppresses dsRNA-Induced Cytotoxicity and Inflammatory Cytokines in Murine Pancreatic Beta Cells and Blocks Viral Acceleration of Type 1 Diabetes in NOD Mice

1
Department of Specialty Medicine, Ohio University Heritage College of Osteopathic Medicine, Athens, OH 45701, USA
2
Department of Biomedical Sciences, Ohio University Heritage College of Osteopathic Medicine, Athens, OH 45701, USA
3
The Diabetes Institute, Ohio University Heritage College of Osteopathic Medicine, Athens, OH 45701, USA
4
Department of Biological Sciences, Ohio University College of Arts & Sciences, Athens, OH 45701, USA
5
Molecular & Cellular Biology Program, Ohio University College of Arts & Sciences, Athens, OH 45701, USA
6
Biomedical Engineering Program, Ohio University Russ College of Engineering & Technology, Athens, OH 45701, USA
7
Department of Natural Sciences, Central Ohio Technical College Newark, OH 43055, USA
*
Author to whom correspondence should be addressed.
Molecules 2013, 18(4), 3841-3858; https://doi.org/10.3390/molecules18043841
Received: 16 February 2013 / Revised: 28 February 2013 / Accepted: 22 March 2013 / Published: 27 March 2013
Accumulating evidence supports a role for viruses in the pathogenesis of type 1 diabetes mellitus (T1DM). Activation of dsRNA-sensing pathways by viral dsRNA induces the production of inflammatory cytokines and chemokines that trigger beta cell apoptosis, insulitis, and autoimmune-mediated beta cell destruction. This study was designed to evaluate and describe potential protective effects of phenylmethimazole (C10), a small molecule which blocks dsRNA-mediated signaling, on preventing dsRNA activation of beta cell apoptosis and the inflammatory pathways important in the pathogenesis of T1DM. We first investigated the biological effects of C10, on dsRNA-treated pancreatic beta cells in culture. Cell viability assays, quantitative real-time PCR, and ELISAs were utilized to evaluate the effects of C10 on dsRNA-induced beta cell cytotoxicity and cytokine/chemokine production in murine pancreatic beta cells in culture. We found that C10 significantly impairs dsRNA-induced beta cell cytotoxicity and up-regulation of cytokines and chemokines involved in the pathogenesis of T1DM, which prompted us to evaluate C10 effects on viral acceleration of T1DM in NOD mice. C10 significantly inhibited viral acceleration of T1DM in NOD mice. These findings demonstrate that C10 (1) possesses novel beta cell protective activity which may have potential clinical relevance in T1DM and (2) may be a useful tool in achieving a better understanding of the role that dsRNA-mediated responses play in the pathogenesis of T1DM. View Full-Text
Keywords: type 1diabetes; dsRNA; beta cell death; phenylmethimazole (C10) type 1diabetes; dsRNA; beta cell death; phenylmethimazole (C10)
Show Figures

Figure 1

MDPI and ACS Style

McCall, K.D.; Schmerr, M.J.; Thuma, J.R.; James, C.B.L.; Courreges, M.C.; Benencia, F.; Malgor, R.; Schwartz, F.L. Phenylmethimazole Suppresses dsRNA-Induced Cytotoxicity and Inflammatory Cytokines in Murine Pancreatic Beta Cells and Blocks Viral Acceleration of Type 1 Diabetes in NOD Mice. Molecules 2013, 18, 3841-3858.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop